Oculis to Present at Upcoming September Investor Conferences
ZUG, Switzerland, Aug. 29, 2024 ( GLOBE NEWSWIRE ) -- Oculis Holding AG ( Nasdaq: OCS ) ( "Oculis" ) , a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis' management will be attending and presenting at the following upcoming ...
| Ticker |
Sentiment |
Impact |
|
AON
|
Neutral
|
12 %
|
|
OCS
|
Bullish
|
71 %
|
